Literature DB >> 30372710

Molluscum contagiosum virus infection can trigger atopic dermatitis disease onset or flare.

Nanette B Silverberg1.   

Abstract

Predisposition to cutaneous viral infections is known to be a minor criterion of Hanifin and Rajka's diagnostic standard of atopic dermatitis (AD); however, the causal relationship between molluscum contagiosum virus (MCV) infection and AD onset or aggravation has not been widely explored. The objective of this study was to identify pediatric patients with AD onset or flare triggered by MCV infection as well as to characterize the setting under which MCV may trigger AD onset or flares in children. Fifty children with prior or current MCV infection presenting sequentially to an outpatient pediatric dermatology practice over a 1-month period were evaluated. Results indicated that children who contract MCV infection may be targets for skin care interventions to prevent and/or control AD.

Entities:  

Mesh:

Year:  2018        PMID: 30372710

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  3 in total

1.  Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum.

Authors:  Lawrence F Eichenfield; Elaine Siegfried; Pearl Kwong; Mark McBride; Jayson Rieger; David Glover; Cynthia Willson; Matthew Davidson; Patrick Burnett; Melissa Olivadoti
Journal:  Am J Clin Dermatol       Date:  2021-02-18       Impact factor: 7.403

Review 2.  Flare management in atopic dermatitis: from definition to treatment.

Authors:  Giampiero Girolomoni; Valentina Maria Busà
Journal:  Ther Adv Chronic Dis       Date:  2022-01-13       Impact factor: 5.091

Review 3.  Skin Dialogues in Atopic Dermatitis.

Authors:  Elena Porumb-Andrese; Claudia Florida Costea; Andrei Cucu; Gabriela Rusu-Zota; Daciana Elena Braisteanu; Vlad Porumb; Mihaela Monica Scutariu; Alexandra Maria Dorobanțu; Ramona Gabriela Ursu
Journal:  Diagnostics (Basel)       Date:  2022-08-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.